Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Hill

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Medicinal Chemistry|May 23, 2009
Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indolesTimothy A Hill, Christopher P Gordon, Andrew B McGeachie, et al.
Antimicrobial Agents and Chemotherapy|January 4, 2019
Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-Resistant and Intracellular <i>Mycobacterium tuberculosis</i>Zeinab G Khalil, Timothy A Hill, Luis M De Leon Rodriguez, et al.
Angewandte Chemie (International Ed. in English)|September 16, 2014
Improving on nature: making a cyclic heptapeptide orally bioavailableDaniel S Nielsen, Huy N Hoang, Rink-Jan Lohman, et al.
European Journal of Medicinal Chemistry|November 9, 2016
Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signalingFabien Plisson, Timothy A Hill, Justin M Mitchell, et al.
Developmental Cell|February 14, 2024
Wnt dose escalation during the exit from pluripotency identifies tranilast as a regulator of cardiac mesodermZhixuan Wu, Sophie Shen, Dalia Mizikovsky, et al.
Journal of Medicinal Chemistry|April 4, 2015
Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) AgonistsHuy N Hoang, Kun Song, Timothy A Hill, et al.
ACS Chemical Biology|May 7, 2013
Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitorsAndrew B McGeachie, Luke R Odell, Annie Quan, et al.
Cancer Research|August 16, 2013
A novel class of anticancer compounds targets the actin cytoskeleton in tumor cellsJustine R Stehn, Nikolas K Haass, Teresa Bonello, et al.
Science Advances|December 1, 2021
De novo macrocyclic peptides for inhibiting, stabilizing, and probing the function of the retromer endosomal trafficking complexKai-En Chen, Qian Guo, Timothy A Hill, et al.
ACS Medicinal Chemistry Letters|October 15, 2014
Cyclic Penta- and Hexaleucine Peptides without N-Methylation Are Orally AbsorbedTimothy A Hill, Rink-Jan Lohman, Huy N Hoang, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Medicinal Chemistry|May 23, 2009
Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indolesTimothy A Hill, Christopher P Gordon, Andrew B McGeachie, et al.
Antimicrobial Agents and Chemotherapy|January 4, 2019
Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-Resistant and Intracellular <i>Mycobacterium tuberculosis</i>Zeinab G Khalil, Timothy A Hill, Luis M De Leon Rodriguez, et al.
Angewandte Chemie (International Ed. in English)|September 16, 2014
Improving on nature: making a cyclic heptapeptide orally bioavailableDaniel S Nielsen, Huy N Hoang, Rink-Jan Lohman, et al.
European Journal of Medicinal Chemistry|November 9, 2016
Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signalingFabien Plisson, Timothy A Hill, Justin M Mitchell, et al.
Developmental Cell|February 14, 2024
Wnt dose escalation during the exit from pluripotency identifies tranilast as a regulator of cardiac mesodermZhixuan Wu, Sophie Shen, Dalia Mizikovsky, et al.
Journal of Medicinal Chemistry|April 4, 2015
Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) AgonistsHuy N Hoang, Kun Song, Timothy A Hill, et al.
ACS Chemical Biology|May 7, 2013
Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitorsAndrew B McGeachie, Luke R Odell, Annie Quan, et al.
Cancer Research|August 16, 2013
A novel class of anticancer compounds targets the actin cytoskeleton in tumor cellsJustine R Stehn, Nikolas K Haass, Teresa Bonello, et al.
Science Advances|December 1, 2021
De novo macrocyclic peptides for inhibiting, stabilizing, and probing the function of the retromer endosomal trafficking complexKai-En Chen, Qian Guo, Timothy A Hill, et al.
ACS Medicinal Chemistry Letters|October 15, 2014
Cyclic Penta- and Hexaleucine Peptides without N-Methylation Are Orally AbsorbedTimothy A Hill, Rink-Jan Lohman, Huy N Hoang, et al.
Pageof 4